Skip to main content
. Author manuscript; available in PMC: 2017 Aug 15.
Published in final edited form as: Cancer. 2016 Jun 27;122(16):2579–2586. doi: 10.1002/cncr.30046

Table 2.

Univariate Logistic Regression with 12-Month Functional Decline/Death

Variable Reference Group Odds (95% CI) p-value
VES Scores at baseline 1.433 (1.252, 1.641) <.0001
Age 1.130 (1.069, 1.194) <.0001
Race: African-American White 2.369 (1.163, 4.827) 0.0175
Education: ≤ High school > High school 4.265 (2.004, 9.077) 0.0002
Marital Status: Other Married 2.602 (1.156, 5.854) 0.0209
Median Household Income (per 1000) 0.979 (0.961, 0.997) 0.0199
Living Situation: Alone Other 1.446 (0.718, 2.909) 0.3015
Employment: Employed Other 0.753 (0.207, 2.735) 0.6661
Health Insurance: Medicare Other 0.747 (0.272, 2.051) 0.5708
Weight: Overweight/Obese Underweight/Normal 1.886 (0.773, 4.601) 0.1631
Charlson’s Comorbidity Index: ≥ 2 < 2 2.173 (1.024, 4.611) 0.0432
Stage: III I – II 3.609 (1.473, 8.842) 0.0050
Chemotherapy: Yes No 0.538 (0.220, 1.319) 0.1756
Hormonal Therapy: Yes No 0.707 (0.297, 1.683) 0.4338
Type of Surgery: Lumpectomy Mastectomy 0.652 (0.301, 1.415) 0.2793
  None Mastectomy 3.750 (0.882, 15.942) 0.0735
Lymph Node Dissection: Yes No 0.523 (0.215, 1.272) 0.1531
Radiation Therapy: Yes No 0.597 (0.288, 1.239) 0.1663
Biological Therapy: Yes No 1.318 (0.537, 3.239) 0.5469
Neoadjuvant Therapy: Yes No 1.517 (0.692, 3.325) 0.2975